These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19001790)

  • 1. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
    Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymus-derived CD4+ CD25+ T cells suppress the development of murine allergic conjunctivitis.
    Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Int Arch Allergy Immunol; 2007; 143(4):276-81. PubMed ID: 17356295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of thymus-derived CD4+CD25+ T cells abrogates the suppressive effects of alpha-galactosylceramide treatment on experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Ueno H; Taguchi O
    Allergol Int; 2008 Sep; 57(3):241-6. PubMed ID: 18493168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A; Sumi T; Fukuda K; Yamaguchi T; Kumagai N; Nishida T; Ueno H
    Immunol Lett; 2006 Sep; 107(1):32-40. PubMed ID: 16930723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
    Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
    Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
    Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.
    Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Immunol Lett; 2007 Jan; 108(1):62-7. PubMed ID: 17109973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
    Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
    Sumi T; Ishida W; Ojima A; Kajisako M; Sakanishi T; Yagita H; Fukushima A
    Immunol Lett; 2008 Aug; 119(1-2):91-6. PubMed ID: 18579220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression.
    Zhang P; Gao F; Wang Q; Wang X; Zhu F; Ma C; Sun W; Zhang L
    Scand J Immunol; 2007 Oct; 66(4):435-40. PubMed ID: 17850588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
    Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
    Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Sumi T; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):705-14. PubMed ID: 17024440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
    Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
    Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.